Previously, we revealed that active PLK1 drives metastasis of NSCLC through expression of catalytic mutants of PLK1 and inhibition of PLK1 activity using PLK1-specific inhibitors or shRNA [25]. Here, PLK1 is linked to non-small cell lung carcinoma.